Home > Healthcare > Medical Devices > Diagnostic Devices > HLA Typing for Transplant Market

HLA Typing for Transplant Market Analysis

  • Report ID: GMI1653
  • Published Date: Nov 2022
  • Report Format: PDF

HLA Typing for Transplant Market Analysis

HLA typing for transplant market from molecular assays technology is anticipated to exceed USD 1.5 billion by 2032. Hospitals, laboratories, and medical centers are rapidly shifting toward molecular assay technology for next-generation sequencing (NGS) in tissue typing. It offers end-users high-throughput, efficient, and DNA sequencers in HLA testing. The growing use of technologies such as NGS, PCR, and RT-PCR in healthcare will further proliferate the use of molecular assay techniques.

 

HLA Typing for Transplant Market Share, By Product & Services

To understand key trends  
Download Free Sample
 

In terms of revenue share, the software segment of the HLA typing for transplant market is estimated to reach USD 250 million by 2032. Software assistance in HLA typing is gaining momentum as the process is time-consuming. Technological advancements have enabled the development of sophisticated software to analyze and compile data through HLA typing. Several industry players are introducing novel software to enhance the efficiency of organ transplant procedures.

 

HLA typing for transplant market from diagnostic labs is projected to surpass USD 943 million by 2032. Over the last few years, the number of HLA testing procedures performed at diagnostic laboratories has increased substantially on account of the increasing frequency of organ transplants. According to the Global Observatory on Donation & Transplantation, approximately 129,681 organ transplant surgeries were performed in 2020. The rising prevalence of genetic conditions, chronic disorders, and physical injuries will fuel the need for HLA typing at diagnostic labs.

 

HLA Typing for Transplant Market Size, By Region

To understand key market trends  
Download Free Sample
 

North America HLA typing for transplant market was more than 35% in 2022. Developed countries like the U.S and Canada with robust healthcare infrastructure and expenditure will positively influence the regional industry landscape. Several government initiatives have been implemented to ensure the ethical execution of organ donation processes along with transplantation programs. These countries have also reported considerable growth in the demand for organ transplants in recent years.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The global market for HLA typing for transplant was worth more than USD 735 million in 2022 and is projected to exhibit over 8.5% CAGR from 2023-2032.

Software is anticipated to reach over USD 250 million by 2032 owing to the development of sophisticated software for data analysis.

North America HLA typing for transplant market was more than 35% in 2022 and is projected to witness substantial growth on account of surging demand for organ transplantation.

Luminex Corporation, Abbott Laboratories, CareDx, Inc., GenDx, Illumina Inc., Immucor Inc., and Biofortuna Limited are some of the major companies in the global market.

HLA Typing for Transplant Market Scope

Buy Now

Access to only 1 person; cannot be shared; cannot be printed
Access for 2 to 5 users only within same department of one company
Access to a company wide audience; includes subsidiary companies or other companies within a group of companies
Immediate Delivery Available

Premium Report Details

  • Base Year: 2022
  • Companies covered: 19
  • Tables & Figures: 372
  • Countries covered: 15
  • Pages: 255
 Download Free Sample